Tiny pump could offer smoother control for rare disorder

NCT ID NCT00743782

Summary

This study tested if delivering a replacement hormone (PTH) through a small, wearable insulin pump is better than twice-daily injections for people with chronic hypoparathyroidism. This rare condition makes it hard for the body to regulate calcium. Researchers wanted to see if the pump could provide steadier, more natural control of calcium levels with a lower dose of medication. The study involved 21 participants, including both adults and children, who tried both methods.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOPARATHYROIDISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, 20892, United States

Conditions

Explore the condition pages connected to this study.